8-Iodo-1-octanol acetate | CAS:75415-20-2

We serve 8-Iodo-1-octanol acetate CAS:75415-20-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
8-Iodo-1-octanol acetate

Chemical Name:8-Iodo-1-octanol acetate
CAS.NO:75415-20-2
Synonyms:8-Iodo-1-octanol acetate
8-iodooctyl acetate
Molecular Formula:C10H19IO2
Molecular Weight:298.16
 
Specification:
Appearance:Colorless to brown liquid
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 8-Iodo-1-octanol acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-iodooctyl acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-iodooctyl acetate Use and application,8-iodooctyl acetate technical grade,usp/ep/jp grade.


Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.8-chlorooct-1-ene manufacturer “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.3-Nitro-N-(2-Hydroxypropyl)-4-Aminophenol supplier “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.2-Bromo-3-methyl-5-nitropyridine vendor In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.